The state of hormonal contraception today: Benefits and risks of hormonal contraceptives: Progestin-only contraceptives

Research output: Contribution to journalArticle

Abstract

The progestin component of hormonal contraceptives accounts for most of their contraceptive effects. Several dosage forms of progestin-only contraceptives have been developed, including pills, injectables, implants, and intrauterine devices. Emergency contraceptives may also contain progestin only and are indicated for prevention of pregnancy following unprotected intercourse or contraceptive failure. Each form has benefits, some specific to the form. An understanding of benefits and risks allows clinicians a wider choice when recommending effective hormonal contraception.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume205
Issue number4 SUPPL.
DOIs
StatePublished - Oct 2011

Fingerprint

Progestins
Contraceptive Agents
Contraception
Postcoital Contraceptives
Intrauterine Devices
Dosage Forms
Pregnancy
Injections

Keywords

  • emergency contraception
  • etonogestrel
  • levonorgestrel
  • medroxyprogesterone acetate
  • norethindrone

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

@article{b124c3c816fa4b948cba5d28d2e82aca,
title = "The state of hormonal contraception today: Benefits and risks of hormonal contraceptives: Progestin-only contraceptives",
abstract = "The progestin component of hormonal contraceptives accounts for most of their contraceptive effects. Several dosage forms of progestin-only contraceptives have been developed, including pills, injectables, implants, and intrauterine devices. Emergency contraceptives may also contain progestin only and are indicated for prevention of pregnancy following unprotected intercourse or contraceptive failure. Each form has benefits, some specific to the form. An understanding of benefits and risks allows clinicians a wider choice when recommending effective hormonal contraception.",
keywords = "emergency contraception, etonogestrel, levonorgestrel, medroxyprogesterone acetate, norethindrone",
author = "Anne Burke",
year = "2011",
month = "10",
doi = "10.1016/j.ajog.2011.04.033",
language = "English (US)",
volume = "205",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4 SUPPL.",

}

TY - JOUR

T1 - The state of hormonal contraception today

T2 - Benefits and risks of hormonal contraceptives: Progestin-only contraceptives

AU - Burke, Anne

PY - 2011/10

Y1 - 2011/10

N2 - The progestin component of hormonal contraceptives accounts for most of their contraceptive effects. Several dosage forms of progestin-only contraceptives have been developed, including pills, injectables, implants, and intrauterine devices. Emergency contraceptives may also contain progestin only and are indicated for prevention of pregnancy following unprotected intercourse or contraceptive failure. Each form has benefits, some specific to the form. An understanding of benefits and risks allows clinicians a wider choice when recommending effective hormonal contraception.

AB - The progestin component of hormonal contraceptives accounts for most of their contraceptive effects. Several dosage forms of progestin-only contraceptives have been developed, including pills, injectables, implants, and intrauterine devices. Emergency contraceptives may also contain progestin only and are indicated for prevention of pregnancy following unprotected intercourse or contraceptive failure. Each form has benefits, some specific to the form. An understanding of benefits and risks allows clinicians a wider choice when recommending effective hormonal contraception.

KW - emergency contraception

KW - etonogestrel

KW - levonorgestrel

KW - medroxyprogesterone acetate

KW - norethindrone

UR - http://www.scopus.com/inward/record.url?scp=80053341759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053341759&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2011.04.033

DO - 10.1016/j.ajog.2011.04.033

M3 - Article

C2 - 21961819

AN - SCOPUS:80053341759

VL - 205

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4 SUPPL.

ER -